New Insights into Cellular Stress Response: A Potential Target for Heart Failure Treatment
Discover how the enzyme NNT influences heart failure with preserved ejection fraction and opens new possibilities for targeted therapies. Research highlights the potential of inhibiting NNT to treat this complex condition.
Researchers from the German Center for Cardiovascular Research (DZHK) have uncovered a significant molecule involved in a form of heart failure known as HFpEF (heart failure with preserved ejection fraction), which has historically proved resistant to targeted therapies. HFpEF occurs when the heart pumps normally but still fails to supply sufficient blood to meet the body's needs, a condition increasingly prevalent among individuals with obesity and hypertension.
The study, led by Professor Johannes Backs at Heidelberg University Hospital, focuses on the enzyme nicotinamide nucleotide transhydrogenase (NNT), located in the mitochondria—the energy-producing structures within cells. NNT plays a crucial role in balancing energy production and protecting cells from oxidative stress caused by free radicals. The research reveals that NNT's activity influences the development of HFpEF by mediating the heart's response to metabolic stresses.
By utilizing a mouse model, scientists found that animals deficient in functional NNT exhibited remarkable resistance to developing HFpEF, despite displaying typical risk factors such as obesity, high blood pressure, and glucose intolerance. This provides compelling evidence that NNT is central to the pathological remodeling of the heart muscle involved in HFpEF. Moreover, the study identified the growth factor FGF1, which is activated by NNT, as being associated with the stiffening of the heart muscle—a key feature of HFpEF.
These findings open promising avenues for developing targeted treatments aimed at inhibiting NNT. Such therapies could potentially mitigate or halt the progression of this complex and often challenging form of heart failure. The research underscores the importance of understanding individual cellular responses to metabolic stress and highlights NNT as a potential therapeutic target for improving heart failure outcomes.
This groundbreaking study has been published in Circulation Research and offers hope for more effective management strategies for patients suffering from HFpEF, which currently lacks specific targeted therapies.
Source: https://medicalxpress.com/news/2025-07-cellular-stress-response-potential-therapeutic.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
New Framework Reclassifies 1 in 5 Overweight Adults as Obese Without Increased Mortality Risk
A new obesity classification framework suggests that 1 in 5 overweight adults are now considered obese, with similar health risks as normal-weight individuals, potentially enabling earlier intervention.
Elevated Air Pollution Levels Are Associated with Worsening Sleep Apnea Symptoms
A large European study reveals that higher levels of air pollution, particularly PM10 particles, are linked to increased severity of obstructive sleep apnea, emphasizing the importance of environmental health for sleep quality and respiratory health.
New Mapping Indicates India Faces the Largest Long-Term Impact from Chikungunya Virus
Recent research reveals that India faces the highest long-term impact from chikungunya, with extensive mapping predicting millions at risk and highlighting the urgent need for targeted prevention strategies.
Identification of Blood Proteins That Predict Future Cognitive Decline
New research from Singapore identifies blood proteins that can predict future cognitive decline and dementia, offering promising avenues for early detection and intervention.